Paul Tudor Jones’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-40,238
| Closed | -$821K | – | 2860 |
|
|
2021
Q4 | $821K | Buy |
+40,238
| New | +$772K | 0.01% | 1131 |
|
|
2020
Q2 | – | Sell |
-23,709
| Closed | -$199K | – | 1489 |
|
|
2020
Q1 | $199K | Buy |
23,709
+5,547
| +31% | +$46.7K | 0.02% | 834 |
|
|
2019
Q4 | $177K | Sell |
18,162
-75,198
| -81% | -$706K | 0.01% | 1005 |
|
|
2019
Q3 | $886K | Sell |
93,360
-14,366
| -13% | -$151K | 0.03% | 540 |
|
|
2019
Q2 | $1.28M | Buy |
107,726
+45,120
| +72% | +$544K | 0.04% | 455 |
|
|
2019
Q1 | $1.1M | Buy |
62,606
+16,713
| +36% | +$278K | 0.05% | 442 |
|
|
2018
Q4 | $797K | Sell |
45,893
-9,846
| -18% | -$168K | 0.02% | 465 |
|
|
2018
Q3 | $831K | Buy |
55,739
+7,570
| +16% | +$117K | 0.02% | 526 |
|
|
2018
Q2 | $766K | Buy |
48,169
+8,865
| +23% | +$132K | 0.03% | 530 |
|
|
2018
Q1 | $558K | Sell |
39,304
-6,738
| -15% | -$99.7K | 0.02% | 524 |
|
|
2017
Q4 | $645K | Sell |
46,042
-3,542
| -7% | -$51.9K | 0.02% | 502 |
|
|
2017
Q3 | $709K | Buy |
49,584
+17,361
| +54% | +$248K | 0.02% | 523 |
|
|
2017
Q2 | $508K | Sell |
32,223
-17,645
| -35% | -$254K | 0.02% | 567 |
|
|
2017
Q1 | $688K | Buy |
49,868
+28,353
| +132% | +$396K | 0.02% | 534 |
|
|
2016
Q4 | $381K | Sell |
21,515
-6,388
| -23% | -$112K | 0.01% | 882 |
|
|
2016
Q3 | $538K | Sell |
27,903
-13,058
| -32% | -$256K | 0.01% | 695 |
|
|
2016
Q2 | $799K | Buy |
40,961
+1,286
| +3% | +$25.2K | 0.02% | 555 |
|
|
2016
Q1 | $818K | Buy |
39,675
+21,457
| +118% | +$423K | 0.02% | 634 |
|
|
2015
Q4 | $374K | Sell |
18,218
-9,495
| -34% | -$182K | 0.01% | 1096 |
|
|
2015
Q3 | $474K | Sell |
27,713
-2,512
| -8% | -$45.9K | 0.02% | 803 |
|
|
2015
Q2 | $563K | Buy |
30,225
+1,100
| +4% | +$20.4K | 0.02% | 706 |
|
|
2015
Q1 | $556K | Sell |
29,125
-11,709
| -29% | -$217K | 0.02% | 677 |
|
|
2014
Q4 | $672K | Buy |
40,834
+16,444
| +67% | +$282K | 0.02% | 563 |
|
|
2014
Q3 | $431K | Buy |
24,390
+13,503
| +124% | +$265K | 0.02% | 766 |
|
|
2014
Q2 | $225K | Sell |
10,887
-17,203
| -61% | -$354K | 0.01% | 981 |
|
|
2014
Q1 | $612K | Buy |
28,090
+20,490
| +270% | +$470K | 0.03% | 416 |
|
|
2013
Q4 | $202K | Sell |
7,600
-5,000
| -40% | -$123K | 0.01% | 1107 |
|
|
2013
Q3 | $298K | Buy |
12,600
+2,800
| +29% | +$65.4K | 0.01% | 595 |
|
|
2013
Q2 | $211K | Buy |
+9,800
| New | +$211K | 0.02% | 710 |
|
Other funds holding VIVO
IC
RA
VLKIM
Paul Tudor Jones's VIVO Position: Q1 2022 in Review
Paul Tudor Jones sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 40,238 shares — an estimated $821K sold.
Paul Tudor Jones first reported a position in VIVO in Q2 2013 and held it in 29 quarters. The position peaked at $1.28M in Q2 2019. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.
- Paul Tudor Jones reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
- Paul Tudor Jones sold 40,238 Meridian Bioscience Inc shares in Q1 2022, an estimated $821K.
- Paul Tudor Jones first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 29 quarters.
- Paul Tudor Jones's Meridian Bioscience Inc position peaked at $1.28M in Q2 2019.
- 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.
Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.